Andersons (ANDE) Form 4: New Director Awarded 2,626 Restricted Share Units
Rhea-AI Filing Summary
Steven Oakland was appointed to the Board of Directors of Andersons, Inc. and received a grant of 2,626 restricted share units (RSUs) on 08/22/2025. Each RSU represents the right to one share of common stock upon vesting. The RSUs vest on 05/07/2026, the issuer's director equity grant vesting date, and reflect 2,626 underlying shares to be delivered on vesting.
Positive
- None.
Negative
- None.
Insights
TL;DR: Director appointment with routine equity grant; typical alignment of new director incentives with shareholder interests.
The filing discloses a board appointment and a standard director equity award: 2,626 RSUs granted on 08/22/2025 that convert 1-for-1 into common shares and vest on 05/07/2026. This is a customary practice to align new directors with long-term shareholder value. The size of the grant is specific but the filing provides no valuation, percent ownership impact, or additional compensation details, limiting assessment of dilution or cost.
TL;DR: Transaction is non-derivative equity compensation for a director; no immediate disposition or sale reported.
The Form 4 reports an acquisition of RSUs (2,626 units) rather than immediate share purchases or dispositions. There is no cash price reported and no other transactions disclosed. The SEC Form 4 shows beneficial ownership following the grant at 2,626 shares (direct). Without share count or market value in the filing, the market impact and dilution cannot be quantified from this document alone.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | RESTRICTED SHARE UNIT (2026) | 2,626 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Each restricted share unit represents the right to receive, upon vesting, one share of the Issuer's common stock. Restricted share units were granted on August 22, 2025, upon his appointment to the Board of Directors. Restricted share units vest on May 7, 2026, the vesting date for the Issuer's 2025 equity grant to directors.